RBC Capital raised the firm’s price target on Teleflex (TFX) to $135 from $130 and keeps a Sector Perform rating on the shares following Q2 results. RBC Capital views Q2 results favorably but noted that Teleflex underlying organic constant currency revenue growth is still tracking to 1%-2% year-over-year and EPS growth at approximately up 50 basis points, the firm told investors. RBC added that the valuation reflects this even as the firm expects expect acceleration into the second half.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TFX:
- Teleflex Raises 2025 Guidance After BIOTRONIK Acquisition
- Teleflex reports Q2 adjusted EPS $3.73, consensus $3.37
- Teleflex raises FY25 adjusted EPS view to $13.90-$14.30 from $13.20-$13.60
- Teleflex price target lowered to $130 from $150 at Mizuho
- Teleflex reports results from study of Arrow Chlorhexidine-Impregnated CVCs